"Modeling a genomic hotspot for psychosis"
Carrie Bearden, PhD, received her PhD in Clinical Psychology from the University of Pennsylvania and joined the UCLA faculty in 2003. Currently, she is a Professor (Joanne and George Miller Family Endowed Term Chair) in the Semel Institute of Neuroscience and Human Behavior at UCLA, with a joint appointment in the Department of Psychology. She is also a member of the Brain Research Institute and Co-Director of the Neurogenetics Track for the Interdeparmental Neuroscience Program. Dr Bearden’s research aims to understand neurobiological risk factors for the development of psychosis, using converging methods across clinical high risk samples and highly penetrant genetic subtypes of illness (e.g., 22q11.2 microdeletions). She is the Director of the Staglin Music Festival Center for the Assessment and Prevention of Prodromal States (CAPPS), part of a multisite consortium which aims to identify biomarkers predicting psychosis onset in at-risk youth. Dr. Bearden has received numerous awards and honors for her work, including Young Investigator Awards from the International Congress on Schizohprenia Research, the National Alliance for Research on Schizophrenia and Affective Disorders (NARSAD), and the American College of Neuropsychopharmacology (ACNP), and the AE Bennett Neuropsychiatric Research Prize for Clinical Science from the Society of Biological Psychiatry. She is passionate about new global neuroscience efforts to advance our understanding of human brain development, typical and atypical.